Cargando…
Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort
Background: The link between Candida phenotypical characteristics and invasive candidiasis (IC) prognosis is still partially unknown. Methods: Candida strains isolated during the AmarCAND2 study were centrally analyzed for species identification, antifungal susceptibility, biofilm formation, and exp...
Autores principales: | Gangneux, Jean-Pierre, Cornet, Muriel, Bailly, Sébastien, Fradin, Chantal, Féger, Céline, Timsit, Jean-François, Leroy, Olivier, Sendid, Boualem, Bougnoux, Marie-Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297146/ https://www.ncbi.nlm.nih.gov/pubmed/30619103 http://dx.doi.org/10.3389/fmicb.2018.02907 |
Ejemplares similares
-
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
por: Leroy, Olivier, et al.
Publicado: (2016) -
Epidemiological cohort study of systemic antifungal therapy for suspected or confirmed invasive candidiasis in the ICU: the Amarcand2 study
por: Constantin, J, et al.
Publicado: (2015) -
Antifungal De-Escalation Is Safe in Critically Ill Patients Treated For Suspected Or Documented Invasive Candidiasis. Data From The Amarcand2 Study
por: Bailly, S, et al.
Publicado: (2015) -
Performance of Repeated Measures of (1–3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial
por: Dupuis, Claire, et al.
Publicado: (2021) -
Antifungal Properties of Hydrazine-Based Compounds against Candida albicans
por: Camaioni, Louis, et al.
Publicado: (2023)